C4130-16X

Organization name

4bases SA

SRN

CH-MF-000042125

Manufacturer status

Active

Primary placement in Italy; available across 1 country total.

Trade name

not provided

UDI-DI code

76404133800118

Basic UDI-DI

764041338C4130UR

Reference / catalog number

C4130-16X

Issuing entity

GS1

Risk category

IVDR Class A

Applicable legislation

IVDR [Regulation (EU) 2017/746 on in vitro diagnostic medical devices]

Status

On the market

Quantity

1

Additional product description

WES Pro is a high-throughput Next-Generation Sequencing (NGS) method that captures and sequences the protein-coding regions (exons) of the human genome, covering approximately 20,000 genes. Although these exonic regions represent only 1% of the genome, they contain up to 85% of pathogenic mutations. Next-generation sequencing (NGS) has become ubiquitous in the investigation of disease at the molecular level. The technology involves millions of nucleic acid strands being read in parallel, one base at a time. The WES Kit is based on short-read sequencing, as it involves reading short fragments of DNA around 300 base pairs.

Additional information URL

https://cloud.4bases.ch/

Clinical sizes

No clinical sizes registered for this device.

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

European Medical Device Nomenclature — the EU product classification assigned to this device.

• W010699GENETIC TESTS - OTHER